Výsledky vyhledávání - "Jizheng Tian"

Akademický článek

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis

Autor: Hongchao Zhen, Jizheng Tian, Guangxin Li, Pengfei Zhao, Ying Zhang, Juanjuan Che, Bangwei Cao

Publikováno v: BMC Cancer, Vol 23, Iss 1, Pp 1-15 (2023)

Abstract Background Anlotinib is a multi-targeted receptor tyrosine kinase inhibitor (TKI) which has exhibited encouraging clinical activity in advanced non-small cell lung cancer (NSCLC) and soft tissue sarcoma. Raltitrexed is well known to be effec

Externí odkaz: https://doaj.org/article/9d0368a2210b4ababf2c4d8cbe0aad45

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Camrelizumab as a novel third or post-third-line treatment strategy in small cell lung cancer: a retrospective study of 12 patients

Autor: Jizheng Tian, Lili Sui, Hong Wang, Xiaoyan Chen

Publikováno v: Frontiers in Oncology, Vol 13 (2023)

BackgroundSmall cell lung cancer (SCLC) constitutes 15% of all lung cancer cases, with a comparatively low survival rate. The advent of immune checkpoint inhibitors (ICIs) has provided new alternatives for treating SCLC. However, the effectiveness of

Externí odkaz: https://doaj.org/article/f0a2d6aebd824354b8702fa98bd51b35

Zobrazit plný text záznamu

Concomitant Statins and the Survival of Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Meta-Analysis

Autor: Lei Zhang, Hong Wang, Jizheng Tian, Lili Sui, Xiaoyan Chen

Publikováno v: International journal of clinical practice. 2022

Statins are suggested to improve cancer survival by possible anti-inflammatory effect. However, it remains unclear if concomitant use of statins could improve the efficacy of immune checkpoint inhibitors (ICIs) in patients with non-small-cell lung ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1e472a87e4f306a8710507026359f1
https://pubmed.ncbi.nlm.nih.gov/35855055

Zobrazit plný text záznamu

Akademický článek

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.

Autor: Zhen, Hongchao¹ (AUTHOR), Tian, Jizheng² (AUTHOR), Li, Guangxin³ (AUTHOR), Zhao, Pengfei⁴ (AUTHOR), Zhang, Ying¹ (AUTHOR), Che, Juanjuan¹ (AUTHOR), Cao, Bangwei¹ (AUTHOR) oncology@ccmu.edu.cn

Publikováno v: BMC Cancer. 3/4/2023, Vol. 23 Issue 1, p1-15. 15p.

Zobrazit plný text záznamu

Plný text ve formátu HTML